首页> 美国卫生研究院文献>Materials >CO-Releasing Materials: An Emphasis on Therapeutic Implications as Release and Subsequent Cytotoxicity Are the Part of Therapy
【2h】

CO-Releasing Materials: An Emphasis on Therapeutic Implications as Release and Subsequent Cytotoxicity Are the Part of Therapy

机译:共释放材料:强调治疗的意义因为释放和随后的细胞毒性是治疗的一部分

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The CO-releasing materials (CORMats) are used as substances for producing CO molecules for therapeutic purposes. Carbon monoxide (CO) imparts toxic effects to biological organisms at higher concentration. If this characteristic is utilized in a controlled manner, it can act as a cell-signaling agent for important pathological and pharmacokinetic functions; hence offering many new applications and treatments. Recently, research on therapeutic applications using the CO treatment has gained much attention due to its nontoxic nature, and its injection into the human body using several conjugate systems. Mainly, there are two types of CO insertion techniques into the human body, i.e., direct and indirect CO insertion. Indirect CO insertion offers an advantage of avoiding toxicity as compared to direct CO insertion. For the indirect CO inhalation method, developers are facing certain problems, such as its inability to achieve the specific cellular targets and how to control the dosage of CO. To address these issues, researchers have adopted alternative strategies regarded as CO-releasing molecules (CORMs). CO is covalently attached with metal carbonyl complexes (MCCs), which generate various CORMs such as CORM-1, CORM-2, CORM-3, ALF492, CORM-A1 and ALF186. When these molecules are inserted into the human body, CO is released from these compounds at a controlled rate under certain conditions or/and triggers. Such reactions are helpful in achieving cellular level targets with a controlled release of the CO amount. However on the other hand, CORMs also produce a metal residue (termed as i-CORMs) upon degradation that can initiate harmful toxic activity inside the body. To improve the performance of the CO precursor with the restricted development of i-CORMs, several new CORMats have been developed such as micellization, peptide, vitamins, MOFs, polymerization, nanoparticles, protein, metallodendrimer, nanosheet and nanodiamond, etc. In this review article, we shall describe modern ways of CO administration; focusing primarily on exclusive features of CORM’s tissue accumulations and their toxicities. This report also elaborates on the kinetic profile of the CO gas. The comprehension of developmental phases of CORMats shall be useful for exploring the ideal CO therapeutic drugs in the future of medical sciences.
机译:释放CO的材料(CORMats)用作产生用于治疗目的的CO分子的物质。一氧化碳(CO)浓度较高时,会对生物产生毒性作用。如果以可控制的方式利用此特征,则它可以充当重要的病理和药代动力学功能的细胞信号传导剂。因此提供了许多新的应用和治疗方法。近年来,由于其无毒的性质,以及使用几种缀合物系统将其注射到人体中,使用CO处理的治疗应用的研究已引起广泛关注。主要地,有两种类型的CO插入人体的技术,即直接和间接CO插入。与直接CO插入相比,间接CO插入具有避免毒性的优点。对于间接的CO吸入方法,开发人员面临某些问题,例如它无法实现特定的细胞靶标以及如何控制CO的剂量。为了解决这些问题,研究人员采用了被视为CO释放分子(CORMs)的替代策略。 )。 CO与金属羰基配合物(MCC)共价连接,后者会生成各种CORM,例如CORM-1,CORM-2,CORM-3,ALF492,CORM-A1和ALF186。将这些分子插入人体后,在某些条件下和/或触发条件下,CO将从这些化合物中释放出来。此类反应有助于通过控制释放的CO量达到细胞水平的目标。但是,另一方面,CORM在降解时也会产生金属残留物(称为i-CORM),这会在体内引发有害的毒性活动。为了在i-CORMs开发受限的情况下提高CO前驱物的性能,已经开发了几种新的CORMats,例如胶束化,肽,维生素,MOF,聚合,纳米颗粒,蛋白质,金属树枝状聚合物,纳米片和纳米金刚石等。文章中,我们将描述CO管理的现代方式;主要关注CORM组织积聚及其毒性的独特功能。该报告还详细阐述了CO气体的动力学特性。对CORMats发展阶段的理解将有助于探索医学未来的理想CO治疗药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号